AS
ALNY icon

Aware Super’s Alnylam Pharmaceuticals ALNY Stock Holding History

Aware Super’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Hold
5,473
– – 0.02% 198
2026
Q1 		$1.81M Buy
+5,473
New +$1.86M 0.03% 207
2025
Q3 		$6.23M Hold
13,665
– – 0.09% 161
2025
Q2 		$4.46M Hold
13,665
– – 0.07% 182
2025
Q1 		$3.69M Hold
13,665
– – 0.06% 185
2024
Q4 		$3.22M Buy
+13,665
New +$3.59M 0.05% 190
2023
Q4 		$2.33M Buy
+5,865
New +$999K 0.03% 206

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aware Super's ALNY Position: Q2 2026 in Review

Aware Super held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 5,473 shares worth $1.65M. The position accounts for 0.02% of the portfolio, ranked #198.

Aware Super first reported a position in ALNY in Q4 2023 and has held it in 7 quarters since. The position peaked at $6.23M in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Aware Super held 5,473 shares of Alnylam Pharmaceuticals worth $1.65M as of Q2 2026.
  • Aware Super left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
  • Alnylam Pharmaceuticals made up 0.02% of Aware Super's portfolio in Q2 2026, its #198 holding.
  • Aware Super first reported a position in Alnylam Pharmaceuticals in Q4 2023 and has held it in 7 quarters since.
  • Aware Super's Alnylam Pharmaceuticals position peaked at $6.23M in Q3 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Aware Super's 13F filing for Q2 2026, filed 29 Jul 2026.